<DOC>
	<DOCNO>NCT00345384</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy , hemodynamic respiratory stability low-dose dexmedetomidine infusion post-operative surgical in-patients undergo thoracic surgery discharge PACU ICU .</brief_summary>
	<brief_title>Dexmedetomidine Control Post-Operative Pain Thoracotomy Patients</brief_title>
	<detailed_description>Dexmedetomidine sedative analgesic property may reduce opioid requirement post-operative patient , thereby decrease chance post-operative respiratory depression occur opioid administration . In addition , patient may alert less opioid medication . Currently , dexmedetomidine approve use longer twenty-four hour must administer Intensive Care Unit patient continuously monitor . This prospective , double-blinded , control group pilot study . One group ( control group ) receive normal saline infusion second group ( treatment group ) receive low-dose Dexmedetomidine 24 hour admit open nursing unit ( Intensive Care Unit ) . During surgery , anesthesiologist administer dexmedetomidine surgical procedure optional loading dose . All patient receive pain medication use Patient Controlled Analgesia ( PCA ) pump per standard practice . In addition , physician deems necessary , On-Q Pain Pump deliver local anesthetic surround incision direction surgeon . Before discharge PACU ICU , subject receive either low-dose dexmedetomidine normal saline use continuous infusion pump 24 hour subject discharge either PACU ICU open nursing unit . While open nurse unit patient vital sign , oxygen saturation , Ramsay score pain score record every two hour treatment drug stop .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) class I , II III Undergoing thoracic surgery inpatient basis Age 18 85 year age Subject pregnant and/or lactate Subject serious Central Nervous System ( CNS ) pathology/trauma , per clinical judgment investigator , preclude responsiveness survival . Subject alpha2 agonist contraindicate Subject meet follow cardiovascular criterion : Acute unstable angina ( define current hospital stay ) Suspicion acute myocardial infarction . Considered leave ventricular ejection fraction le 30 % .Decision exclude predicate Investigator 's opinion , may base combination acute presentation , recently preform diagnostic study , history suggest poor cardiac function . Pulmonary congestion noncardiac origin mild congestive failure primarily attributable etiology poor ventricular function exclusion criterion . Subject participate trial experimental drug within 30 day prior enrollment study , ever enrol study . Subject unable undergo procedure require protocol . Subject acute hepatitis , history presence chronic hepatitis , /or positive result Hepatitis B surface antigen test . Subject require dialysis ( e.g. , hemodialysis , peritoneal dialysis , CVVHD ) . Subject know , uncontrolled seizure disorder . Subject know psychiatric illness could confound normal response sedative treatment . Subject terminally ill life duration expectancy &lt; 60 day . Subject history Obstructive Sleep Apnea . Oxygen saturation &lt; 90 % room air . Subject beta blocker medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Sedation</keyword>
	<keyword>Opioid</keyword>
	<keyword>Respiratory depression</keyword>
</DOC>